FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by ...

Roche posted higher sales that beat analysts’ expectations on higher demand for its key drugs.

The Swiss National Bank said on Thursday it posted a first quarter profit of 6.7 billion Swiss francs ($8.08 billion), as ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose 7% to 15.44 billion Swiss francs ($18.64 billion) and it ...

The price of Donald Trump's cryptocurrency has soared after the US president promised to host two special events for its top ...

These hummocky features come in all sizes from a few metres to hundreds of metres in length and are popular with skiers, ...

Asian shares traded mixed Thursday, as worries crept back following a Wall Street rally that came after President Donald ...

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana. Roche, a Swiss company, ...

The company says it is “prioritizing localized production to reduce exposure to international cost swings.” And the polyol ...

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

Swiss and French pharmaceutical companies Novartis and Sanofi are pushing for higher medicine prices in Europe. This content ...